Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Finch Therapeutics Presents Positive Data from PRISM3 Clinical Trial of CP101 for Recurrent C.,

Results from PRISM3, a Phase 2, randomized, placebo-controlled, multi-center clinical trial evaluating the investigational orally administered …, Results from PRISM3, a Phase 2, randomized, placebo-controlled, multi-center clinical trial evaluating the investigational orally administered …, Read More

Scroll to Top